Falsified Medicines Directive in the news: ABPI concerns and the German perspective
With the Falsified Medicines Directive (FMD) coming into full force tomorrow (9 February 2019), two stories have highlighted the need … read more »
Second draft of the Law for more safety in the supply of pharmaceuticals (GSAV) approved by the German Federal Cabinet
In response to drug scandals in Germany this year, including the possible contamination of drugs with potentially carcinogenic substances and … read more »
German BPI expresses concern over the consequences of a ‘no deal’ Brexit
Yesterday the Chairman of the German Federal Association of the Pharmaceutical Industry (BPI) released a statement expressing concern after Parliament … read more »
BPI (Germany) warns against rushing new mechanism for benefit assessment
The CEO of the Association of the Pharmaceutical Industry (Germany) (BPI), Martin Zentgraf, has expressed concern regarding a draft law … read more »
German draft bill introduces compulsory registries for orphan medicinal products (OMPs) and marketing authorisations (MA) under conditional approval or exceptional circumstances, and encourages uptake of biosimilars
In response to drug scandals in Germany this year, including the possible contamination of drugs with potentially carcinogenic substances and … read more »
Calls for faster uptake of biosimilars in Germany
In an interview with the Handelsblatt newspaper Germany’s health minister Jens Spahn has stated there should be faster uptake of … read more »
Germany to market 18 new antibiotics before 2020
One of the biggest challenges facing the pharmaceutical industry is antimicrobial resistance (AMR), where pathogens become resistant to multiple drugs. Infections … read more »
German Federal Health Minister discusses current challenges for the German healthcare system
German Federal Health Minister, Jens Spahn, took part in an interview on 26 October 2018, discussing current challenges for the German … read more »
National Action Alliance for People with Rare Diseases secures future funding
In Germany, the Association of Research-based Pharmaceutical Companies (VFA) and the Federation of the Pharmaceutical Industry (BPI) have welcomed the … read more »
BPI release cautious critique of latest AMNOG figures
The BPI, Germany’s Federal Association of the Pharmaceutical Industry, have released a cautionary note explaining some of their concerns with … read more »
